Chessman Wealth Strategies RIA’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-14,696
Closed -$112K 8
2019
Q2
$112K Hold
14,696
0.61% 13
2019
Q1
$77K Hold
14,696
0.07% 21
2018
Q4
$96K Hold
14,696
0.1% 23
2018
Q3
$253K Hold
14,696
0.22% 27
2018
Q2
$205K Buy
+14,696
New +$248K 0.18% 27

Other funds holding PGEN

Chessman Wealth Strategies RIA's PGEN Position: Q3 2019 in Review

Chessman Wealth Strategies RIA sold out of Precigen (PGEN) in Q3 2019, closing a stake of 14,696 shares — an estimated $112K sold.

Chessman Wealth Strategies RIA first reported a position in PGEN in Q2 2018 and held it in 5 quarters. The position peaked at $253K in Q3 2018. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2019.

  • Chessman Wealth Strategies RIA reported no remaining Precigen position as of Q3 2019 after selling out during the quarter.
  • Chessman Wealth Strategies RIA sold 14,696 Precigen shares in Q3 2019, an estimated $112K.
  • Chessman Wealth Strategies RIA first reported a position in Precigen in Q2 2018 and held it in 5 quarters.
  • Chessman Wealth Strategies RIA's Precigen position peaked at $253K in Q3 2018.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2019.

Based on Chessman Wealth Strategies RIA's 13F filing for Q3 2019, filed 25 Oct 2019.